Comparison of two regimens for patients with thyroid‑associated ophthalmopathy receiving intravenous methyl prednisolone: A single center prospective randomized trial-Reference-Cited by-同舟云学术

Comparison of two regimens for patients with thyroid‑associated ophthalmopathy receiving intravenous methyl prednisolone: A single center prospective randomized trial

Published:2020-10-06 Issue:6 Volume:20 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Mu Pan-Wei¹,Tang Xi-Xiang²,Wang Yi-Na²,Lin Shuo¹,Wang Man-Man¹,Yin Qiong-Li²,Shu Jiong¹,Zhu Bi-Lian²,Li Jing-Ren¹,Zhou Li¹,Zeng Long-Yi¹,Chen Yan-Ming¹

Affiliation:

1. Department of Endocrinology, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China

2. Advanced Medical Center, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review With Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2024-07-30

2. A comprehensive epigenetic network can influence the occurrence of thyroid-associated ophthalmopathy by affecting immune and inflammatory response;Scientific Reports;2024-06-12

3. Identification of potential immunotherapeutic targets and prognostic biomarkers in Graves' disease using weighted gene co-expression network analysis;Heliyon;2024-03

4. Specific immune status in patients with active thyroid-associated orbitopathy before and after methylprednisolone therapy;2023-10-06

5. Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy;International Ophthalmology;2023-09-12